Literature DB >> 17277117

High IFN-gamma production of individual CD8 T lymphocytes is controlled by CD152 (CTLA-4).

Pushpa Pandiyan1, J Kolja E Hegel, Manuela Krueger, Dagmar Quandt, Monika C Brunner-Weinzierl.   

Abstract

CD8 T cell expansion and cytokine production is needed to generate an effective defense against viral invasion of the host. These features of CD8 T lymphocytes are regulated, especially during primary responses, by positive and negative costimulation. We show in this study that surface expression of CD152 is highly up-regulated on activated CD8 T lymphocytes during primary immune responses, suggesting a prominent regulatory role. Indeed, production of the proinflammatory cytokine IFN-gamma, but not TNF-alpha, by CD8 T cells was inhibited by CD152 engagement. The inhibition was regulated independent of proliferation and IL-2 production, but dependent on the quality of the TCR signaling. We show that signals induced by CD152 on activated CD8 T lymphocytes reduce the frequency of IFN-gamma(high)-expressing cells. Our data also show that in activated CD8 T cells, the CD152-mediated inhibition of cytokine production is more pronounced than inhibition of their proliferation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17277117     DOI: 10.4049/jimmunol.178.4.2132

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  ICAM-1-dependent homotypic aggregates regulate CD8 T cell effector function and differentiation during T cell activation.

Authors:  Nicholas A Zumwalde; Eisuke Domae; Matthew F Mescher; Yoji Shimizu
Journal:  J Immunol       Date:  2013-08-30       Impact factor: 5.422

2.  Recombinant adeno-associated virus vectors induce functionally impaired transgene product-specific CD8+ T cells in mice.

Authors:  Shih-Wen Lin; Scott E Hensley; Nia Tatsis; Marcio O Lasaro; Hildegund C J Ertl
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

3.  The differentiation and plasticity of Tc17 cells are regulated by CTLA-4-mediated effects on STATs.

Authors:  Aditya Arra; Holger Lingel; Benno Kuropka; Jonas Pick; Tina Schnoeder; Thomas Fischer; Christian Freund; Mandy Pierau; Monika C Brunner-Weinzierl
Journal:  Oncoimmunology       Date:  2017-01-20       Impact factor: 8.110

4.  Inhibition of T-cell activation attenuates hypertension, TNFα, IL-17, and blood-brain barrier permeability in pregnant rats with angiogenic imbalance.

Authors:  Cynthia Bean; Shauna-Kay Spencer; Teylor Bowles; Patrick B Kyle; Jan M Williams; Jacob Gibbens; Kedra Wallace
Journal:  Am J Reprod Immunol       Date:  2016-08-01       Impact factor: 3.886

5.  Associations between cytotoxic T lymphocyte-associated antigen-4 polymorphisms and serum tumor necrosis factor-α and interferon-γ levels in patients with chronic hepatitis B virus infection.

Authors:  Qunying Han; Shaoqiong Duan; Guoyu Zhang; Zhu Li; Na Li; Qianqian Zhu; Yi Lv; Jinghong Chen; Zhengwen Liu
Journal:  Inflamm Res       Date:  2011-08-17       Impact factor: 4.575

6.  CD28 ligation increases macrophage suppression of T-cell proliferation.

Authors:  Daniel Silberman; Amanda Bucknum; Thomas Bartlett; Gabriella Composto; Megan Kozlowski; Amanda Walker; Amy Werda; Jackelyn Cua; Arlene H Sharpe; John E Somerville; James E Riggs
Journal:  Cell Mol Immunol       Date:  2012-04-23       Impact factor: 11.530

Review 7.  Memories that last forever: strategies for optimizing vaccine T-cell memory.

Authors:  Jeffrey D Ahlers; Igor M Belyakov
Journal:  Blood       Date:  2009-11-10       Impact factor: 22.113

8.  CTLA-4 co-receptor impacts on the function of Treg and CD8+ T-cell subsets.

Authors:  Christopher E Rudd
Journal:  Eur J Immunol       Date:  2009-03       Impact factor: 5.532

9.  Increased HLA-DMB expression in the tumor epithelium is associated with increased CTL infiltration and improved prognosis in advanced-stage serous ovarian cancer.

Authors:  Michael J Callahan; Zoltan Nagymanyoki; Tomas Bonome; Michael E Johnson; Babak Litkouhi; Elizabeth H Sullivan; Michelle S Hirsch; Ursula A Matulonis; Joyce Liu; Michael J Birrer; Ross S Berkowitz; Samuel C Mok
Journal:  Clin Cancer Res       Date:  2008-12-01       Impact factor: 12.531

10.  Molecular networks involved in the immune control of BK polyomavirus.

Authors:  Eva Girmanova; Irena Brabcova; Jiri Klema; Petra Hribova; Mariana Wohlfartova; Jelena Skibova; Ondrej Viklicky
Journal:  Clin Dev Immunol       Date:  2012-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.